Literature DB >> 25025994

The ICAM-1 K469E polymorphism is associated with the risk of coronary artery disease: a meta-analysis.

Daolin Li1, Chunsheng Qu, Pingshuan Dong.   

Abstract

BACKGROUND: The intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism has been indicated to be correlated with coronary artery disease (CAD) susceptibility, but the results of studies are still debatable. Thus, a meta-analysis was carried out.
METHODS: Databases including PubMed, Embase, Web of Science, and CNKI were searched. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated.
RESULTS: Eighteen studies with 3546 cases and 3852 controls were included in this meta-analysis. The association between the ICAM-1 K469E polymorphism and the risk of CAD was significant (OR=1.77; 95% CI, 1.52-2.05; P<0.01; I=27%). This result remained statistically significant when the adjusted ORs were combined (OR=1.95; 95% CI, 1.78-2.14; P<0.01; I=0%). When stratified by ethnicity, a significantly increased risk was observed in Whites (OR=1.75; 95% CI, 1.37-2.23; P<0.01; I=58%) and in Asians (OR=1.80; 95% CI, 1.45-2.24; P<0.01; I=0%). A significantly increased risk of myocardial infarction was observed (OR=2.24; 95% CI, 1.72-2.92; P<0.01; I=38%).
CONCLUSION: In conclusion, this meta-analysis suggested that the ICAM-1 K469E polymorphism was a risk factor for CAD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25025994     DOI: 10.1097/MCA.0000000000000136

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  9 in total

Review 1.  ICAM-1 molecular mechanism and genome wide SNP's association studies.

Authors:  C Anbarasan; M Bavanilatha; K Latchumanadhas; S Ajit Mullasari
Journal:  Indian Heart J       Date:  2015-05-16

2.  A noninvasive method for coronary artery diseases diagnosis using a clinically-interpretable fuzzy rule-based system.

Authors:  Hamid Reza Marateb; Sobhan Goudarzi
Journal:  J Res Med Sci       Date:  2015-03       Impact factor: 1.852

3.  Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease.

Authors:  BiHong Liao; KeQi Cheng; ShaoHong Dong; HuaDong Liu; ZhengLei Xu
Journal:  Diagn Pathol       Date:  2015-07-16       Impact factor: 2.644

Review 4.  ICAM-1 gene rs5498 polymorphism decreases the risk of coronary artery disease.

Authors:  Ailing Liu; Ailing Wan; Aifang Feng; Ruping Rui; Bingzhi Zhou
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

5.  A Allele of ICAM-1 Rs5498 and VCAM-1 Rs3181092 is Correlated with Increased Risk for Periodontal Disease.

Authors:  Qijun Sun; Zongxin Zhang; Yuejian Ou
Journal:  Open Life Sci       Date:  2019-12-31       Impact factor: 0.938

6.  Associations between the rs5498 (A > G) and rs281432 (C > G) polymorphisms of the ICAM1 gene and atherosclerotic cardiovascular disease risk, including hypercholesterolemia.

Authors:  Naruemon Wechjakwen; Amornrat Aroonnual; Pattaneeya Prangthip; Ngamphol Soonthornworasiri; Pornpimol Panprathip Phienluphon; Jirayu Lainampetch; Karunee Kwanbunjan
Journal:  PeerJ       Date:  2022-03-08       Impact factor: 2.984

7.  HO-1 Upregulation by Kaempferol via ROS-Dependent Nrf2-ARE Cascade Attenuates Lipopolysaccharide-Mediated Intercellular Cell Adhesion Molecule-1 Expression in Human Pulmonary Alveolar Epithelial Cells.

Authors:  Chien-Chung Yang; Li-Der Hsiao; Chen-Yu Wang; Wei-Ning Lin; Ya-Fang Shih; Yi-Wen Chen; Rou-Ling Cho; Hui-Ching Tseng; Chuen-Mao Yang
Journal:  Antioxidants (Basel)       Date:  2022-04-14

8.  Efficacy and safety of eight types Salvia miltiorrhiza injections in the treatment of unstable angina pectoris: A network meta-analysis.

Authors:  Mingxuan Li; Hongdian Li; Hongxu Liu; Xiaolei Lai; Wenlong Xing
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

9.  Intercellular adhesion molecule 1 rs5498 polymorphism is associated with the risk of myocardial infarction.

Authors:  Pengfei Hu; Tao Dai; Weiwei Yu; Ying Luo; Shuwei Huang
Journal:  Oncotarget       Date:  2017-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.